Author:
Chen Junyu,Lu Hezhen,Cao Dongyan,Sun Jiameng,Qi Feng,Liu Xiaoyan,Liu Jiaqi,Yang Jiaxin,Yu Mei,Zhou Huimei,Cheng Ninghai,Wang Jinhui,Zhang Ying,Peng Peng,Wang Tao,Shen Keng,Sun Wei
Funder
National High Level Hospital Clinical Research Funding
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference53 articles.
1. Sung, H., Ferlay, J., Siegel, R. L., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA., 71(3), 209–249.
2. McCluggage, W. G. (2006). My approach to the interpretation of endometrial biopsies and curettings. Journal of Clinical Pathology., 59(8), 801–812.
3. Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999). “Metabonomics”: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29(11), 1181–1189.
4. Bingol, K. (2018). Recent advances in targeted and untargeted metabolomics by NMR and MS/NMR methods. High-Throughput, 7(2), 7.
5. Kobayashi, T., Nishiumi, S., Ikeda, A., et al. (2013). A novel serum metabolomics-based diagnostic approach to pancreatic cancer. Cancer Epidemiology, Biomarkers & Prevention, 22(4), 571–579.